nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials
|
Yeh, Celine |
|
|
204 |
1 |
p. 39-47 |
artikel |
2 |
A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer
|
Mayer, Erica L. |
|
|
204 |
1 |
p. 123-132 |
artikel |
3 |
Association between body mass index and outcomes after autologous breast reconstruction: a nationwide inpatient database study in Japan
|
Karakawa, Ryo |
|
|
204 |
1 |
p. 69-78 |
artikel |
4 |
Association between prediabetes and breast cancer: a comprehensive meta-analysis
|
Keesari, Praneeth Reddy |
|
|
204 |
1 |
p. 1-13 |
artikel |
5 |
Association of clinicopathologic and molecular factors with the occurrence of positive margins in breast cancer
|
Praveen Kumar, Anupama |
|
|
204 |
1 |
p. 15-26 |
artikel |
6 |
Breast cancers in monoallelic MUTYH germline mutation carriers have clinicopathological features overlapping with those in BRCA1 germline mutation carriers
|
Keske, Aysenur |
|
|
204 |
1 |
p. 151-158 |
artikel |
7 |
Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants
|
Schwartz, Christopher J. |
|
|
204 |
1 |
p. 171-179 |
artikel |
8 |
“Enhancing survival outcomes through breast-conserving therapy in ipsilateral breast tumor recurrence: insights into metastasis and treatment strategies”
|
Mokbel, Kefah |
|
|
204 |
1 |
p. 187 |
artikel |
9 |
FTO is a major genetic link between breast cancer, obesity, and diabetes
|
Gholami, Morteza |
|
|
204 |
1 |
p. 159-169 |
artikel |
10 |
Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis
|
Li, Huiyue |
|
|
204 |
1 |
p. 89-105 |
artikel |
11 |
Incidence and risk factors of hypothyroidism after treatment for early breast cancer: a population-based cohort study
|
Digkas, Evangelos |
|
|
204 |
1 |
p. 79-87 |
artikel |
12 |
Northern origin of the BRCA2 c.5286 T > G founder allele
|
Yanus, Grigory A. |
|
|
204 |
1 |
p. 191 |
artikel |
13 |
Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer
|
Olsson, Linnea T. |
|
|
204 |
1 |
p. 107-116 |
artikel |
14 |
Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients
|
Zwager, Mieke C. |
|
|
204 |
1 |
p. 27-37 |
artikel |
15 |
Prevalence of targetable genomic alterations in young women with advanced breast cancer: a cross-sectional study
|
Blansky, Deanna |
|
|
204 |
1 |
p. 181-185 |
artikel |
16 |
Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer
|
Accordino, Melissa K. |
|
|
204 |
1 |
p. 49-59 |
artikel |
17 |
Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene
|
Yahya, Shaymaa M. M. |
|
|
204 |
1 |
p. 133-149 |
artikel |
18 |
Superparamagnetic iron oxide (SPIO) for axillary mapping in patients with ductal carcinoma in situ undergoing mastectomy: single-institution experience
|
Addae, Jamin Kweku |
|
|
204 |
1 |
p. 117-121 |
artikel |
19 |
The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population
|
Alaeikhanehshir, Sena |
|
|
204 |
1 |
p. 61-68 |
artikel |
20 |
The role of endocrine treatment on the risk of developing an ipsilateral invasive breast cancer in hormone receptor positive patients with ductal carcinoma in situ
|
Altundag, Kadri |
|
|
204 |
1 |
p. 189-190 |
artikel |